M&T BANK CORP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$132,000
-31.2%
28,648
-6.1%
0.00%0.0%
Q3 2021$192,000
+3.8%
30,521
-1.1%
0.00%0.0%
Q2 2021$185,000
-5.1%
30,8600.0%0.00%0.0%
Q1 2021$195,000
+2.6%
30,860
-8.1%
0.00%0.0%
Q4 2020$190,000
-3.1%
33,587
+0.0%
0.00%0.0%
Q3 2020$196,000
+3.2%
33,577
+27.7%
0.00%0.0%
Q2 2020$190,000
+54.5%
26,290
-0.2%
0.00%0.0%
Q1 2020$123,000
-38.8%
26,341
+4.9%
0.00%0.0%
Q4 2019$201,000
+33.1%
25,108
+14.5%
0.00%0.0%
Q3 2019$151,000
-11.7%
21,920
+6.2%
0.00%0.0%
Q2 2019$171,000
-17.4%
20,640
-0.8%
0.00%0.0%
Q1 2019$207,00020,8060.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders